# METHOTREXATE SODIUM
> **ANDA216453** · Abbreviated New Drug Application (Generic) · Sponsor: ELITE LABS INC · Approved 2024-05-16
## Drug
- **FDA Application Number:** ANDA216453
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHOTREXATE SODIUM
- **Generic name:** METHOTREXATE SODIUM
- **Active ingredients:** METHOTREXATE SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ELITE LABS INC
- **Manufacturer:** Elite Laboratories, Inc.
- **First approval:** 2024-05-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216453)
---
*AI Analytics · CC0 1.0*